|
V.COV
|
datruth, I was wrong, the value of your opinion is clearly illustrated in...
|
|
V.COV
|
Why don't you reference their actual financial results, like the 54...
|
|
V.COV
|
Chlorhexidine-sivler combination products provide superior protecion against...
|
|
V.COV
|
A couple new products are highlighted in their Medica trade show PR:
Medica...
|
|
V.COV
|
Molnlycke has created dedicated websites for the new products here:
http...
|
|
V.IVS
|
Not sure why this news prompted selling today, other than the mention of the...
|
|
T.MBX
|
Options granted, not exercised, not necessarily reason for excitement...
|
|
V.IVS
|
It's not immediately possitive news, but the follow-up could be good IMO....
|
|
V.COV
|
Yes, per GAAP only the "in the money" options and warrants are...
|
|
V.COV
|
Read the financial statetments. On page 24 of their Inerim financial...
|
|
V.COV
|
I just look at COV as having 20M shares fully diluted; but even at that COV...
|
|
T.MBX
|
No, the short answer is that new method Novartis is using is what is called a...
|
|
V.COV
|
Covalon doesn't have much of a following YET, so we're going to have...
|
|
V.COV
|
Thanks for the history lesson; but that was six years ago and the company...
|
|
T.MBX
|
Rocketed you're right, you go ahead and hold your breath for the company...
|
|
T.MBX
|
Let's keep it real people, our company has plenty going for it without...
|
|
T.MBX
|
Thanks for the link, I was busy earlier and didn't notice the link...
|
|
T.MBX
|
Don't think that is us, I don't see any actual connection to our...
|
|
V.IVS
|
I think the assumption of 10 G per ton accross the entire deposit is a bit...
|
|
T.MBX
|
I agree fundamentally on everything you say about the strength of the case...
|